Pancreatic Cancer Research

ResearcherNo recent work listed

Mamoru Suzuki

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-7071-5093; OpenAlex author ID A5065673016. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
2
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: 1 paper

Papers 2

  1. Retrospective study of gemcitabine plus S-1 versus gemcitabine alone in cases with unresectable advanced pancreatic cancer. Last author DOI 10.5754/hge121235↗
  2. [Effectiveness of adjuvant chemotherapy using gemcitabine for resected pancreatic cancer]. Co-author PMID 21368460↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Shuji Suzuki · 2 shared papers, 2011–2013 · strength 0.06
  2. Fujio Hanyu · 1 shared paper, 2011 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.